Burke Neurological Institute (BNI) is deeply saddened by the passing of an incredibly kind and thoughtful colleague, Dr. M. Flint Beal. As one of the greatest clinician-scientists of his generation, Dr.
The research team examined how myeloid cells can also facilitate repair by clearing debris and promoting tissue remodeling during the early stages of repair. The study showed that a transcription factor, hypoxia-inducible factor, which the Ratan lab has been studying for years, marks myeloid cells that are associated with good long term recovery.
Host John Torpey, director of the Ralph Bunche Institute, speaks with Dr. Rajiv Ratan, Burke Professor of Neurology and Neuroscience at Weill Cornell Medicine, about the emergence of the novel coronavirus from a biological perspective.
May 6, 2020 – Featured on the cover of Cell Chemical Biology, a new and significant review article by Dr. Raj Ratan, Executive Director of the Burke Neurological Institute, examines “The Chemical Biology of Ferroptosis in the Central Nervous System.”
For the first time in 85 years, Mercy College is saluting graduates at a Virtual Commencement Ceremony. Dr. Raj Ratan is delivering remarks as one of four Honorary Degree recipients. Dr. Ratan is being honored for his demonstrated leadership, lifetime achievements and outstanding contributions to society.
Johns Hopkins University announced with great honor to induct Dr. Raj R. Ratan, executive director of Burke Neurological Institute, into the John Hopkins Society of Scholars. Each year, the Society of Scholars Selection Committee elects a limited number of scholars, artists, and scientists who spent a portion of their careers at Johns Hopkins from among the candidates nominated by Johns Hopkins University faculty.
On Thursday, January 23, 2020, it was a privilege to host Professor Lawal S. Bilbis, Vice-Chancellor of the Usmanu Danfodiyo University, Sokoto Nigeria for a visit of the Burke Neurological Institute. Dr. Bilbis is the mentor of Nasiru Suleiman, a Fulbright Visiting Scholar training on stroke pathophysiology in the Preclinical Stroke Modeling Laboratory under Dr. Sunghee Cho.
Burke Neurological Institute is pleased to share our highlights and impacts achieved during 2019. Together, we renew hope to those living with neurological disabilities by helping people to see, remember, talk, write, and walk again. Enjoy these accomplishments from 2019 as we look forward to a bright 2020!
Burke Neurological Institute is very grateful to our Board of Trustees, faculty, staff, patients, families, and friends. Thank you for bringing our mission to life and for supporting our efforts to advance the Science that Hope Demands!
The chemical element selenium, an essential nutrient for humans and other animals, protects the brain after a stroke and may be a basis for future stroke therapies, according to a study from scientists at Burke Neurological Institute and Weill Cornell Medicine.
A team of scientists have discovered that selenium, a micronutrient, can help boost the antioxidant system on the heels of stroke in animals and suggests that a similar treatment could be used to limit brain damage in patients. Stroke is a leading cause of disability and death in the United States, occurring once every 40 seconds.
The Burke Neurological Institute, the University of Rochester Medical Center and Wadsworth Center of the NYS Department of Health (NYSDOH) were recently awarded a $5 million grant from the Empire State Development Corporation to enable NeuroCuresNY (NCNY) to launch a two-year pilot starting in January 2020.
Burke Neurological Institute invites interested and qualified undergraduate students to apply to our Summer Science Research Program. The 10-week program will run from June through August 2019. Learn more >
With great honor, Dr. Raj Ratan, executive director of Burke Neurological Institute, has been invited to serve as a member of the Neural Oxidative Metabolism and Death Study Section, Center for Scientific Review for the term beginning July 01, 2018 and ending June 30, 2024.
On March 2nd, a manuscript from the Burke Medical Research Institute describing a novel drug for improving outcomes following brain hemorrhage was published in Science’s sister journal, Science Translational Medicine.